Cynomolgus monkey's choroid reference database derived from hybrid deep learning optical coherence tomography segmentation.

Journal: Scientific reports
PMID:

Abstract

Cynomolgus monkeys exhibit human-like features, such as a fovea, so they are often used in non-clinical research. Nevertheless, little is known about the natural variation of the choroidal thickness in relation to origin and sex. A combination of deep learning and a deterministic computer vision algorithm was applied for automatic segmentation of foveolar optical coherence tomography images in cynomolgus monkeys. The main evaluation parameters were choroidal thickness and surface area directed from the deepest point on OCT images within the fovea, marked as the nulla with regard to sex and origin. Reference choroid landmarks were set underneath the nulla and at 500 µm intervals laterally up to a distance of 2000 µm nasally and temporally, complemented by a sub-analysis of the central bouquet of cones. 203 animals contributed 374 eyes for a reference choroid database. The overall average central choroidal thickness was 193 µm with a coefficient of variation of 7.8%, and the overall mean surface area of the central bouquet temporally was 19,335 µm and nasally was 19,283 µm. The choroidal thickness of the fovea appears relatively homogeneous between the sexes and the studied origins. However, considerable natural variation has been observed, which needs to be appreciated.

Authors

  • Peter M Maloca
    OCTlab, Department of Ophthalmology, University of Basel, Basel, Switzerland.
  • Christian Freichel
    Pharma Research and Early Development (pRED), Pharmaceutical Sciences (PS), Roche, Innovation Center Basel, 4070, Basel, Switzerland.
  • Christof Hänsli
    Berner Augenklinik Am Lindenhofspital and University of Bern, Bern, Switzerland.
  • Philippe Valmaggia
    Institute of Molecular and Clinical Ophthalmology Basel (IOB), 4031, Basel, Switzerland.
  • Philipp L Müller
    Universitäts-Augenklinik Bonn, Bonn, Deutschland.
  • Sandrine Zweifel
    Department of Ophthalmology, University Hospital Zurich, Zurich, Switzerland.
  • Christine Seeger
    Pharma Research and Early Development (pRED), Pharmaceutical Sciences (PS), Roche, Innovation Center Basel, 4070, Basel, Switzerland.
  • Nadja Inglin
    Institute of Molecular and Clinical Ophthalmology Basel (IOB), 4031, Basel, Switzerland.
  • Hendrik P N Scholl
    Department of Ophthalmology, University of Basel, Basel, Switzerland.
  • Nora Denk
    Department of Ophthalmology, University of Basel, Basel, Switzerland.